Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
03/1996
03/27/1996EP0702562A1 Cyclosporin-containing powder composition
03/27/1996EP0702561A1 Treatment of neuromuscular disorders and conditions with different botulinum serotype
03/27/1996EP0702560A1 Immunologic enhancement with intermittent interleukin-2 therapy
03/27/1996EP0702559A1 Multiple botulinum toxins for treating neuromuscular disorders and conditions
03/27/1996EP0702558A1 Novel opioid peptide inhibitors
03/27/1996EP0702557A1 Therapeutic inhibitor of vascular smooth muscle cells
03/27/1996EP0702553A1 Water soluble non-immunogenic polyamide cross-linking agents
03/27/1996EP0702518A1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
03/27/1996EP0702516A1 Genetic immunization with cationic lipids
03/27/1996EP0662836A4 Germicidal detergent-iodine compositions having reduced detergent content.
03/27/1996EP0607392A4 Plasma fraction purification.
03/27/1996EP0593506B1 Lipoaminoacids, preparation method and applications
03/27/1996EP0509989B1 Method of preparing ribonuclease dimers
03/27/1996EP0448644B1 Transdermal estrogen/progestin dosage unit and system.
03/27/1996CN1119459A Process for preparing cancer vaccines
03/27/1996CN1119458A Nucleic acid pharmaceuticals
03/27/1996CN1119457A Bone stimulating factor
03/27/1996CN1119442A Protein Rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
03/27/1996CN1119441A AZA cyclohexapeptide compounds
03/27/1996CN1119121A Crystalline interleukin-4
03/26/1996US5502167 CDR grafted humanised chimeric T-cell antibodies
03/26/1996US5502166 Information transmission at a synapse, central nervous systems
03/26/1996US5502164 Peptide compounds having therapeutic activity
03/26/1996US5502163 By lactating cows
03/26/1996US5502077 Fatty acid composition
03/26/1996US5502061 Peptidyl substituted benzamides and naphthamies
03/26/1996US5502037 Antitumor agents for procytotoxic drugs
03/26/1996US5502036 Viricides
03/26/1996US5502035 Hormone inhibitors
03/26/1996US5502034 Methods for producing thrombin
03/26/1996US5502033 Antimicrobial polypeptide compound a pharmaceutical composition comprising the same, and a method for treating infectious diseases
03/26/1996US5502032 Peptides, the preparation and use thereof
03/26/1996US5501969 Bone disorders, antitumor
03/26/1996US5501962 Culture of cells for polypeptides
03/26/1996US5501854 Comprising first and second portions having affinities for cellular target and bioactive molecules respectively; therapy, medical diagnosis
03/26/1996US5501853 Peptide plasminogen activators
03/26/1996CA2062582C Methods and substances for recruiting therapeutic agents to solid tissues
03/26/1996CA2041044C Large intestinal dissociative polypeptide series oral formulation
03/26/1996CA1338183C Cyclic peptolides
03/21/1996WO1996008781A1 System and method of automatically generating chemical compounds with desired properties
03/21/1996WO1996008574A1 Novel implant and novel vector for the treatment of acquired diseases
03/21/1996WO1996008565A2 RECOMBINANT PEPTIDES DERIVED FROM THE Mc3 ANTI-BA46 ANTIBODY, METHODS OF USE THEREOF, AND METHODS OF HUMANIZING ANTIBODY PEPTIDES
03/21/1996WO1996008564A1 Humanised antibody to integrin chain beta-1
03/21/1996WO1996008563A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin
03/21/1996WO1996008562A1 Biologically active molecules derived from neurotrophins
03/21/1996WO1996008561A1 Method for detection of malfolded protein
03/21/1996WO1996008560A1 Transduction of genes into human hematopoietic stem cells using recombinant adeno-associated viral vectors
03/21/1996WO1996008559A1 Glycosaminoglycan-degrading enzyme inhibition and resultant disease therapies
03/21/1996WO1996008558A1 Modulation of drug radiation resistant genes
03/21/1996WO1996008557A1 Human inositol monophosphatase h1
03/21/1996WO1996008517A1 Water-soluble dextran fatty acid esters and their use as solubilisers
03/21/1996WO1996008516A1 PORCINE ANTIBODIES TO TNF-α(ALPHA)
03/21/1996WO1996008515A1 Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites
03/21/1996WO1996008514A1 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
03/21/1996WO1996008513A1 Cytotactin derivatives that stimulate attachment and neurite outgrowth, and methods of making and using same
03/21/1996WO1996008512A1 POLYPEPTIDES WITH Fc BINDING ABILITY
03/21/1996WO1996008510A1 Hu-B1.219, A NOVEL HUMAN HEMATOPOIETIN RECEPTOR
03/21/1996WO1996008509A1 Anti-fungal peptides
03/21/1996WO1996008508A1 A new human peptide antibiotic (fall-39) and its use
03/21/1996WO1996008507A1 Aza cyclohexapeptide compounds
03/21/1996WO1996008506A1 Phosphorus-32 labeling of antibodies for cancer therapy
03/21/1996WO1996008275A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase
03/21/1996WO1996008274A2 Conjugates of heparin-binding epidermal growth factor-like growth factor with targeted agents
03/21/1996WO1996008272A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria
03/21/1996WO1996008271A1 Protection of hemopoietic cells during chemotherapy or radiotherapy
03/21/1996WO1996008270A2 Method for inhibiting sexually transmitted diseases using magaining antimicrobials or squalamine compounds
03/21/1996WO1996008269A1 Inhibition of human rotavirus infection
03/21/1996WO1996008268A1 Inhibition of endothelin-1 to reduce inflammatory processes
03/21/1996WO1996008267A1 Semi-synthetic lipopeptides, compositions containing said lipopeptides, and methods of use
03/21/1996WO1996008266A1 Aza cyclohexapeptide compounds
03/21/1996WO1996008265A1 Corticotropin release inhibiting factor and methods of using same
03/21/1996WO1996008264A1 Synthetic antibiotics
03/21/1996WO1996008263A1 Intracellular delivery of chemical agents to a specific cell type
03/21/1996WO1996008262A1 Composition and method for immunotherapy
03/21/1996WO1996008256A1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof
03/21/1996WO1996008231A1 Control of hair growth
03/21/1996WO1996006108A3 Cyclic cs-1 peptidomimetics, compositions and methods of using the same
03/21/1996WO1996005309A3 Modulators of body weight, corresponding nucleic acids and proteins, and diagnostic and therapeutic uses thereof
03/21/1996WO1996002272A3 Treatment of autoimmune diseases
03/21/1996WO1995034679A3 Defects in drug metabolism
03/21/1996WO1995033819A3 Cdk4 (cyclin dependent kinase 4) binding proteins
03/21/1996WO1995032290A3 Non-a/non-b/non-c/non-d/non-e hepatitis agents and molecular cloning thereof
03/21/1996DE4435485C1 Verfahren zur Gewinnung von hochreinem von Willebrand-Faktor Process for the recovery of high purity von Willebrand factor
03/21/1996DE4433479A1 Proteins isolated from Boophilus microplus
03/21/1996DE4433458A1 Proteins isolated from Desserobdella leeches
03/21/1996DE4433101A1 Wasserlösliche Dextranfettsäureester und ihre Verwendung als Solubilisatoren Water-soluble dextran fatty and their use as solubilizers
03/21/1996DE4432942A1 New synthetic inducible biological response amplifier
03/21/1996DE3249946C2 Target cell lysis factor prodn.
03/21/1996CA2200097A1 Recombinant peptides derived from the mc3 anti-ba46 antibody, methods of use thereof, and methods of humanizing antibody peptides
03/21/1996CA2200088A1 Phosphorus-32 labeling of antibodies for cancer therapy
03/21/1996CA2200085A1 Control of hair growth
03/21/1996CA2199939A1 Inhibition of endothelin-1 to reduce inflammatory processes
03/21/1996CA2199820A1 Modulation of drug radiation resistant genes
03/21/1996CA2199749A1 Humanised antibody to integrin chain beta-1
03/21/1996CA2199746A1 Secretory leukocyte protease inhibitor as an inhibitor of tryptase
03/21/1996CA2199740A1 Monoclonal antibodies against human colon carcinoma-associated antigens and uses therefor
03/21/1996CA2199734A1 Corticotropin release inhibiting factor and methods of using same
03/21/1996CA2199730A1 Protection of hemopoietic cells during chemotherapy or radiotherapy
03/21/1996CA2199719A1 Process for manufacture of a modified collagen-induced platelet aggregation inhibitor pallidipin
03/21/1996CA2199707A1 Inhibition of human rotavirus infection
1 ... 2797 2798 2799 2800 2801 2802 2803 2804 2805 2806 2807 2808 2809 2810 2811 2812 2813 2814 2815 2816 2817 ... 3163